Comment on: ‘Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada’, Wilson et al., 22 June 2018

by Ashleigh McGirr, Shehzad M. Iqbal, Jan Olbrecht, Lijoy Varghese
Published 2018-11-01

How to assess for the full economic value of vaccines? From past to present, drawing lessons for the future

by Baudouin Standaert, Christophe Sauboin, Rodrigo DeAntonio, Alen Marijam, Jorge Gomez, Lijoy Varghese, Sharon Zhang
Published 2020-01-01

Health economic assessment of a rabies pre-exposure prophylaxis program compared with post-exposure prophylaxis alone in high-risk age groups in the Philippines

by Beatriz Quiambao, Lijoy Varghese, Nadia Demarteau, Ruth Faye Sengson, Jenaline Javier, Piyali Mukherjee, Leah Cheryl Manio, Scott Preiss
Published 2020-08-01